Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Britain hosts G7 health summit amid pressure to broaden COVID vaccine access

Thu, 03rd Jun 2021 16:02

* CEPI urges G7 nations to donate COVID vaccines

* G7 split on issue of temporary waiver on vaccine patents

* UK says to agree on early warning system for next pandemic
(Adds CEPI interview)

By Alistair Smout

LONDON, June 3 (Reuters) - Britain hosted health ministers
from the Group of Seven (G7) rich countries in Oxford on
Thursday for a two-day summit, as pressure intensifies to do
more to broaden access to COVID-19 vaccines across the world.

British foreign minister Dominic Raab has said that
equitable access to coronavirus vaccines will be at the top of
the agenda when G7 leaders meet next week.

As health ministers gathered at the University of Oxford,
where AstraZeneca's COVID-19 vaccine was invented,
Richard Hatchett, chief executive of the Coalition for Epidemic
Preparedness Innovations (CEPI), said there was a moral duty for
G7 countries to start donating COVID-19 vaccines now.

"We must send vaccines to countries to protect their health
care workers and protect the vulnerable populations now,"
Hatchett told Reuters.

"G7 meetings don't always occur with a crisis of global
proportions and historic impact, and this is a critical, once in
a generation G7 meeting," he said.

Charities also stressed Britain could do more by supporting
a temporary waiver on intellectual property rights of
pharmaceutical firms.

U.S. President Joe Biden has backed calls from many
developing countries for the waiver, in the hope this would
boost production and allow more equitable distribution, but
Britain and some European countries have expressed reservations.

"G7 leaders must take this moment to stand on the right side
of history by putting their full support behind the vaccine
patent waiver," said Anna Marriott, Oxfam’s Health Policy
Manager.

"The G7 may be getting the vaccines they need but too much
of the world is not and people are paying for patent protection
with their lives."

Britain has said technology transfers with not-for-profit
pricing, a model AstraZeneca has used, can achieve many of the
same aims as a patent waiver without disincentivising research.

British health minister Matt Hancock said he would agree
with G7 counterparts on a system to share data on any early
warning signs of the next pandemic.

"Globally we are only as strong as the weakest link in the
health security chain. No one is safe until everyone is safe,"
Hancock said in a statement.
(Reporting by Alistair Smout; Editing by Mark Potter and Toby
Chopra)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.